1. LBA61A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer. (1st October 2019) Authors: Gershenson, D M; Miller, A; Brady, W; Paul, J; Carty, K; Rodgers, W; Millan, D; Coleman, R L; Moore, K N; Banerjee, S; Connolly, K; Secord, A A; O'Malley, D M; Dorigo, O; Gaillard, S; Gabra, H; Hanjani, P; Huang, H; Wenzel, L; Gourley, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗